Matches in SemOpenAlex for { <https://semopenalex.org/work/W1971596494> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W1971596494 endingPage "610" @default.
- W1971596494 startingPage "607" @default.
- W1971596494 abstract "Summary: Twenty-four newly diagnosed and previously untreated infantile spasm patients were treated for 3 weeks with either methysergide (12 patients) or a-methylparatyrosine (12 patients). Response to therapy was determined objectively with 24-h polygraphic/video monitoring techniques and was defined as cessation of spasms and disappearance of the hypsarrhythmic EEG pattern. Two (17%) of the patients treated with a-methylparatyrosine responded to therapy, and one (8%) of the methysergide-treated group showed a response. RÉSUMÉ Vingt-quatre patients non traités chez lesquels des spasmes infantiles venaient d'être diagnostiquls ont bénéficié pendant trois semaines d'un traitement par méthysergide (12 patients) ou α-méthylparatyrosine (12 patients). La réponse au traitement a été jugée de façon objective, au moyen d'une surveillance poly-graphique et vidéo de 24 heures, et a été définie comme l'arrêt des spasmes et la disparition de l'activité EEG hypsarythmique. Deux des patients traités par α-méthylparatyrosine ont répondu au traitement (soit 17%), et un des patients traités par méthyser-gide a répondu au traitement (soit 8%). La signification de ces constatations est discutée. RESUMES Durante tres semanas, un grupo de 24 enfermos recientemente diagnosticados de espasmos infantiles sin tratmiento previo, ha sido tratado con metisergida (12 pacientes) o alfa-metiloparatirosina (12 casos). La respuesta a la terapeútica se determineó objetivamente utilizando técnicas de monitorización poligráfica/video durante 24 horas y se definió como una inter-rupción de los espasmos y una desaparición del partón ipsarrít-mico del EEG. Dos de los pacientes (17%) tratados con alfa-metilparatirosina mostraron buena respuesta y uno (8%) del grupo tratado con metisergida tembtén respondió. Se discute el significado de los resultados. ZUSAMMENFASSUNG 24 neu auftetretene und nicht vorbehandelte Kinder mit BNS-Krämpfen wurden für 3 Wochen entweder mit Methysergide (12 Pat.) oder Alpha-Methylparatyrosin (12 Pat.) behandelt. Der Therapie-erfolg wurde objektiviert durch: 24-h-Polygraphie und Videoaufnahmen. Als Anfallsfreiheit wurde definiert das Versch-winden von Krämpfen und Hypsarrhythmie im EEG. 2 (17%) mit Alpha-Methylparatyrosin behandelte Patienten und 1 (8%) mit Methysergide sprachen auf die Therapie an. Die Signifikanz des Ergebnis wird diskutiert." @default.
- W1971596494 created "2016-06-24" @default.
- W1971596494 creator A5011312063 @default.
- W1971596494 creator A5019048637 @default.
- W1971596494 creator A5067780710 @default.
- W1971596494 creator A5084790454 @default.
- W1971596494 date "1989-10-01" @default.
- W1971596494 modified "2023-10-15" @default.
- W1971596494 title "Treatment of Infantile Spasms with Methysergide and α-Methylparatyrosine" @default.
- W1971596494 cites W1965803425 @default.
- W1971596494 cites W1984499016 @default.
- W1971596494 cites W2019541385 @default.
- W1971596494 cites W2041447261 @default.
- W1971596494 cites W2051098266 @default.
- W1971596494 cites W2067235410 @default.
- W1971596494 cites W2082217101 @default.
- W1971596494 cites W2142225000 @default.
- W1971596494 cites W2314337218 @default.
- W1971596494 doi "https://doi.org/10.1111/j.1528-1157.1989.tb05480.x" @default.
- W1971596494 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2571497" @default.
- W1971596494 hasPublicationYear "1989" @default.
- W1971596494 type Work @default.
- W1971596494 sameAs 1971596494 @default.
- W1971596494 citedByCount "17" @default.
- W1971596494 countsByYear W19715964942013 @default.
- W1971596494 countsByYear W19715964942016 @default.
- W1971596494 countsByYear W19715964942022 @default.
- W1971596494 crossrefType "journal-article" @default.
- W1971596494 hasAuthorship W1971596494A5011312063 @default.
- W1971596494 hasAuthorship W1971596494A5019048637 @default.
- W1971596494 hasAuthorship W1971596494A5067780710 @default.
- W1971596494 hasAuthorship W1971596494A5084790454 @default.
- W1971596494 hasConcept C126322002 @default.
- W1971596494 hasConcept C141071460 @default.
- W1971596494 hasConcept C170493617 @default.
- W1971596494 hasConcept C2775864247 @default.
- W1971596494 hasConcept C2781005078 @default.
- W1971596494 hasConcept C29456083 @default.
- W1971596494 hasConcept C71924100 @default.
- W1971596494 hasConceptScore W1971596494C126322002 @default.
- W1971596494 hasConceptScore W1971596494C141071460 @default.
- W1971596494 hasConceptScore W1971596494C170493617 @default.
- W1971596494 hasConceptScore W1971596494C2775864247 @default.
- W1971596494 hasConceptScore W1971596494C2781005078 @default.
- W1971596494 hasConceptScore W1971596494C29456083 @default.
- W1971596494 hasConceptScore W1971596494C71924100 @default.
- W1971596494 hasIssue "5" @default.
- W1971596494 hasLocation W19715964941 @default.
- W1971596494 hasLocation W19715964942 @default.
- W1971596494 hasOpenAccess W1971596494 @default.
- W1971596494 hasPrimaryLocation W19715964941 @default.
- W1971596494 hasRelatedWork W1506200166 @default.
- W1971596494 hasRelatedWork W1995515455 @default.
- W1971596494 hasRelatedWork W2048182022 @default.
- W1971596494 hasRelatedWork W2049296172 @default.
- W1971596494 hasRelatedWork W2080531066 @default.
- W1971596494 hasRelatedWork W2748952813 @default.
- W1971596494 hasRelatedWork W2899084033 @default.
- W1971596494 hasRelatedWork W3031052312 @default.
- W1971596494 hasRelatedWork W3032375762 @default.
- W1971596494 hasRelatedWork W3108674512 @default.
- W1971596494 hasVolume "30" @default.
- W1971596494 isParatext "false" @default.
- W1971596494 isRetracted "false" @default.
- W1971596494 magId "1971596494" @default.
- W1971596494 workType "article" @default.